Evidence map›Paper›PMID 29808008›Full record

ArticleNature medicine2018

Convergence of placenta biology and genetic risk for schizophrenia.

Gianluca Ursini, Giovanna Punzi, Qiang Chen, Stefano Marenco, Joshua F Robinson, Annamaria Porcelli, Emily G Hamilton, Marina Mitjans, Giancarlo Maddalena, Martin Begemann and 13 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 142 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
142citing papers in PubMed, 1 pooled it
56.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

142 citing papers in PubMed, 1 synthesis or guideline pooled it, 285 citations in OpenAlex.

  1. Vitamin D and schizophrenia: 20 years on.Molecular psychiatry · 2021
    Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Synergistic pathways to psychosis: understanding developmental risk and resilience factors.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  12. Transdiagnostic prevention in youth mental health, Part I: rationale, shared risk factors.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  13. Schizophrenia.Nature reviews. Disease primers · 2025
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

82 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 9 institutions in 5 countries.

Gianluca UrsiniLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA.
Giovanna PunziLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA.
Qiang ChenLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA.
Stefano MarencoClinical and Translational Neuroscience Branch, National Institute of Mental Health, Intramural Research Program, National Institutes of Health, Bethesda, MD, USA.
Joshua F RobinsonCenter for Reproductive Sciences, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, CA, USA.
Annamaria PorcelliGroup of Psychiatric Neuroscience, Department of Basic Medical Science, Neuroscience and Sense Organs, Aldo Moro University, Bari, Italy.
Emily G HamiltonCenter for Reproductive Sciences, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, CA, USA.
Marina MitjansClinical Neuroscience, Max Planck Institute of Experimental Medicine, DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain, Göttingen, Germany.
Giancarlo MaddalenaGroup of Psychiatric Neuroscience, Department of Basic Medical Science, Neuroscience and Sense Organs, Aldo Moro University, Bari, Italy.
Martin BegemannClinical Neuroscience, Max Planck Institute of Experimental Medicine, DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain, Göttingen, Germany.
Jan SeidelClinical Neuroscience, Max Planck Institute of Experimental Medicine, DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain, Göttingen, Germany.
Hidenaga YanamoriDepartment of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.
Andrew E JaffeLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-6886-1454
Karen F BermanClinical and Translational Neuroscience Branch, National Institute of Mental Health, Intramural Research Program, National Institutes of Health, Bethesda, MD, USA.
Michael F EganMerck Research Laboratories, Merck and Co., Inc., Whitehouse Station, NJ, USA.
Richard E StraubLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA.
Carlo ColantuoniDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Giuseppe BlasiGroup of Psychiatric Neuroscience, Department of Basic Medical Science, Neuroscience and Sense Organs, Aldo Moro University, Bari, Italy.ORCID http://orcid.org/0000-0003-0878-1131
Ryota HashimotoDepartment of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.ORCID http://orcid.org/0000-0002-5941-4238
Dan RujescuDepartment of Psychiatry, Psychotherapy, and Psychosomatics, Martin Luther University of Halle-Wittenberg, Halle, Germany.
Hannelore EhrenreichClinical Neuroscience, Max Planck Institute of Experimental Medicine, DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain, Göttingen, Germany.
Alessandro BertolinoGroup of Psychiatric Neuroscience, Department of Basic Medical Science, Neuroscience and Sense Organs, Aldo Moro University, Bari, Italy.
Daniel R WeinbergerLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA. drweinberger@libd.org.
Johns Hopkins University · USMax Planck Institute of Experimental Medicine · DEUniversity of Bari Aldo Moro · ITNational Institutes of Health · USThe University of Osaka · JPUniversity of California, San Francisco · USUniversity of Maryland, Baltimore · USMartin Luther University Halle-Wittenberg · DEMerck & Co., Inc., Rahway, NJ, USA (United States) · US

Funding

Imaging of Neuropsychiatric Disorders with Developmental and Genetic MechanismsZIAMH002652 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI BERMAN, KAREN FAITH · 2009 to 2025
$17.3M
Multimodal Imaging: Genetic and Environmental Effects in NeuropsychiatryZIAMH002942 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI BERMAN, KAREN FAITH · 2013 to 2022
$12.2M
6 · The paper itself

Abstract

Defining the environmental context in which genes enhance disease susceptibility can provide insight into the pathogenesis of complex disorders. We report that the intra-uterine environment modulates the association of schizophrenia with genomic risk (in this study, genome-wide association study-derived polygenic risk scores (PRSs)). In independent samples from the United States, Italy, and Germany, the liability of schizophrenia explained by PRS is more than five times greater in the presence of early-life complications (ELCs) compared with their absence. Patients with ELC histories have significantly higher PRS than patients without ELC histories, which is confirmed in additional samples from Germany and Japan. The gene set composed of schizophrenia loci that interact with ELCs is highly expressed in placenta, is differentially expressed in placentae from complicated in comparison with normal pregnancies, and is differentially upregulated in placentae from male compared with female offspring. Pathway analyses reveal that genes driving the PRS-ELC interaction are involved in cellular stress response; genes that do not drive such interaction implicate orthogonal biological processes (for example, synaptic function). We conclude that a subset of the most significant genetic variants associated with schizophrenia converge on a developmental trajectory sensitive to events that affect the placental response to stress, which may offer insights into sex biases and primary prevention.

Indexed as

Genetic Predisposition to DiseaseCase-Control StudiesFemaleGene Expression RegulationGenome, HumanGenome-Wide Association StudyHumansLife Change EventsMaleMultifactorial InheritancePlacentaPolymorphism, Single NucleotidePregnancyRisk FactorsSchizophreniaSex Characteristics

Identifiers

PMID29808008
OpenAlexW2803229193

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.